Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.8475
-0.0034 (-0.40%)
At close: Jul 16, 2025, 4:00 PM
0.8448
-0.0027 (-0.32%)
After-hours: Jul 16, 2025, 4:00 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $30.65 million as of July 16, 2025. Its market cap has decreased by -9.40% in one year.
Market Cap
30.65M
Enterprise Value
29.46M
1-Year Change
-9.40%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $30.65M, an increase of 1,624.25%. That is a compound annual growth rate of 182.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 30.77M | -29.14% |
| Dec 31, 2024 | 43.43M | 11.15% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 710.14B |
| Johnson & Johnson | 396.09B |
| AbbVie | 335.69B |
| Novo Nordisk | 299.09B |
| UnitedHealth Group | 266.82B |
| Novartis AG | 234.87B |
| Abbott Laboratories | 228.77B |
| AstraZeneca | 217.99B |